China's Ascentage Pharma climbs as chairman buys shares on market

Ascentage Pharma International

29/09/2026 07:52

** Shares of Ascentage Pharma Group International 6855.HK climb 3.9% to HK$30.62, on course for their biggest one-day pct gain since September 21
** The company, which develops treatments for blood cancers, says its chairman Yang Dajun has bought 38,630 shares, or 0.01% of the share capital, on the market for HK$1.16 million ($148,000)
** Yang's stake in the company increases to 62.57 million shares on completion of the deal, representing 16.69% of the total issued share capital, Ascentage says
** Ascentage adds Yang's share purchase indicates his confidence in the company's prospects
** YTD, stock down 41.6%, while Hang Seng Biotech Index .HSBIO up 12.9%  



($1 = 7.8444 Hong Kong dollars)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))